Ms Ugne Balaseviciute, a pre-doctoral researcher in the Translational Research in the Hepatic Oncology Group at Institut D'Investigacions Biomediques August Pi i Sunyer (IDIBAPS) Barcelona, Spain.

A new drug called WNTinib can delay the growth of tumors and improve survival in hepatoblastoma, a type of liver cancer that ...

A new drug called WNTinib can delay the growth of tumours and improve survival in hepatoblastoma, a type of liver cancer that ...

A research team led by Prof. Zhou Rongbin from the University of Science and Technology of China (USTC) discovered the ...

A research team led by Prof. ZHOU Rongbin from the University of Science and Technology of China (USTC) discovered the ...

A group of researchers at VCU Massey Comprehensive Cancer Center was awarded $13 million by the National Cancer Institute.

October is Liver Cancer Awareness Month. Liver cancer is the third-leading cause of cancer-related deaths worldwide, and the ...

The FDA has already made more than a dozen cancer drug approval decisions this year and more expected in the next several ...

From “Boy Meets World” actress Danielle Fishel discussing her breast cancer surgery to a young TikTok star dying from a rare ...

A research team analyzed how diabetes mellitus and obesity factor into recurrence and survival after surgery for hepatocellular carcinoma, a type of liver cancer. Hepatocellular carcinoma ...

Tumors—both cancerous or benign (harmless)—that affect the liver, biliary system, or pancreas may disrupt bile acid production or bile flow, leading to various symptoms such as pale stool.

Nonalcoholic fatty liver disease (NAFLD) develops when fat builds up in your liver. Over time, it can become more severe and cause inflammation and other damage to your liver. Experts renamed ...